We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $15.1B
1-Year Est. Return 27.93%
This Fund
S&P 500
This Quarter Est. Return
-0.71%
1 Year Est. Return
+27.93%
3 Year Est. Return
+64.69%
5 Year Est. Return
+64.07%
10 Year Est. Return
AUM
$3.54B
AUM Growth
+$107M
Cap. Flow
+$179M
Cap. Flow %
5.05%
Top 10 Hldgs %
20.31%
Holding
4,474
New
404
Increased
1,575
Reduced
1,479
Closed
707
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOUG icon
3501
Douglas Elliman
DOUG
$166M
$277 ﹤0.01%
169
+161
+2,013% +$373
VMD icon
3502
Viemed Healthcare
VMD
$336M
$276 ﹤0.01%
+30
New +$250
INNV icon
3503
InnovAge Holding
INNV
$1.47B
$273 ﹤0.01%
+34
New +$254
IBCP icon
3504
Independent Bank Corp
IBCP
$818M
$266 ﹤0.01%
8
+3
+60% +$103
STCE icon
3505
Schwab Crypto Thematic Natural Language Processing ETF
STCE
$225M
$265 ﹤0.01%
5
WVVI icon
3506
Willamette Valley Vineyards
WVVI
$11.2M
$257 ﹤0.01%
100
QTEX
3507
QTREX Quantum
QTEX
$55.9M
$256 ﹤0.01%
573
METCB icon
3508
Ramaco Resources Class B
METCB
$467M
$255 ﹤0.01%
+25
New +$302
ATLO icon
3509
AMES National
ATLO
$280M
$254 ﹤0.01%
+9
New +$236
OPLN
3510
Openlane
OPLN
$4.28B
$254 ﹤0.01%
23
+14
+156% +$404
MPAA icon
3511
Motorcar Parts of America
MPAA
$218M
$254 ﹤0.01%
+6
New +$69
DNA icon
3512
Ginkgo Bioworks
DNA
$469M
$252 ﹤0.01%
41
+38
+1,267% +$316
PKOH icon
3513
Park-Ohio Holdings
PKOH
$663M
$240 ﹤0.01%
+10
New +$245
BEAM icon
3514
Beam Therapeutics
BEAM
$3.03B
$238 ﹤0.01%
10
-65
-87% -$1.8K
LENZ
3515
LENZ Therapeutics
LENZ
$161M
$238 ﹤0.01%
+26
New +$365
PNRG icon
3516
PrimeEnergy Resources
PNRG
$332M
$233 ﹤0.01%
+1
New +$192
BRCB
3517
Black Rock Coffee Bar Inc
BRCB
$203M
$233 ﹤0.01%
+18
New +$292
AVBH
3518
Avidbank Holdings
AVBH
$348M
$228 ﹤0.01%
+8
New +$226
PCB icon
3519
PCB Bancorp
PCB
$386M
$225 ﹤0.01%
+10
New +$223
IPSC icon
3520
Century Therapeutics
IPSC
$366M
$224 ﹤0.01%
99
KLTR icon
3521
Kaltura
KLTR
$244M
$223 ﹤0.01%
+183
New +$260
APPS icon
3522
Digital Turbine
APPS
$1.34B
$219 ﹤0.01%
76
+51
+204% +$219
DAVA icon
3523
Endava
DAVA
$170M
$217 ﹤0.01%
49
LEGN icon
3524
Legend Biotech
LEGN
$3.87B
$217 ﹤0.01%
12
ASIC
3525
Ategrity Specialty Insurance
ASIC
$1.27B
$217 ﹤0.01%
+11
New +$213

Similar funds

Arax Advisory Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Arax Advisory Partners held 4,474 positions worth $3.54B, up 3.1% from $3.43B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Arax Advisory Partners deployed $179M of net new capital in Q1 2026, opening 404 new positions and adding to 1,575 existing holdings. Its largest new stake was FT Vest US Equity Moderate Buffer ETF August: 789,886 shares worth $30.6M.

By sector, the portfolio is most concentrated in Miscellaneous at 70% of assets, up from 68% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares Core US Aggregate Bond ETF, an estimated $32.9M trimmed.

  • Arax Advisory Partners's largest Q1 2026 buy was FT Vest US Equity Moderate Buffer ETF August: 789,886 shares worth $30.6M.
  • Arax Advisory Partners added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $59M increase.
  • Arax Advisory Partners's biggest Q1 2026 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $32.9M.
  • Arax Advisory Partners fully exited Willis Towers Watson in Q1 2026, selling an estimated $746K.
  • Arax Advisory Partners's ten largest holdings make up 20% of its $3.54B portfolio in Q1 2026.
  • Arax Advisory Partners opened 404 new positions and closed 707 in Q1 2026.
  • Arax Advisory Partners's portfolio value rose 3.1% quarter-over-quarter to $3.54B.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.